NEW AWARD FOR OXCARBAZEPINE WITH XLCARE PHARMACEUTICALS. PERIOD OF PERFORMANCE IS OCT 14, 2024 TO OCT 13, 2025 WITH FOUR ONE-YEAR OPTIONS
$11,065,099
| Recipient | XLCARE PHARMACEUTICALS INC UEI MEAUS5WHBJJ7 |
|---|---|
| Award ID | 36E79724D0034 |
| Award amount | $11,065,099 |
| Award type | — |
| Awarding agency | Department of Veterans Affairs — Department of Veterans Affairs |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Oct 14, 2024 |
| End date | — |
| Place of performance | — |
| Record updated | Aug 15, 2024 |
View the official award record
More awards won by XLCARE PHARMACEUTICALS INC
NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS.
Department of Veterans Affairs · $54,110,891 · Nov 11, 2023
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $50,000,000 · Jun 1, 2026
NEW AWARD FOR LEVOTHYROXINE NA TABLETS WITH XLCARE PHARMACEUTICALS, INC. BASE YEAR ORDERING PERIOD IS JAN 27, 2025 THROUGH JAN 26, 2026 WITH FOUR ONE-YEAR OPTIONS
Department of Veterans Affairs · $40,144,392 · Jan 27, 2025
NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.
Department of Veterans Affairs · $37,933,103 · Sep 24, 2025
NEW AWARD FOR PANTOPRAZOLE TABLETS WITH XLCARE PHARMACEUTICALS. ORDERING PERIOD IS JUNE 26, 2022 TO JUNE 25, 2023 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $28,973,376 · Jun 26, 2022
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids